NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Knudsen, Lars ^a,b,c   Atochina Vasserman, Elena N ^d   Guo, Chang Jiang ^e   Scott, Pamela A ^e   Haenni, Beat ^a   Beers, Michael F ^d   Ochs, Matthias ^a,b,c   Gow, Andrew J ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Biomedical Research in Endstage and Obstructive Lung Disease Hannover ^*  (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; FIZZ1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PTGS2 PROTEIN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; YM1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DINOS MICE; EMPHYSEMA; GENE EXPRESSION; HOMEOSTASIS; HYPERTROPHY; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG PARENCHYMA; LUNG RESISTANCE; MOUSE; NONHUMAN; NOS2 GENE; PNEUMONIA; SFTPD DEFICIENT MICE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION; HOMEOSTASIS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; RESPIRATORY FUNCTION TESTS;

EID: 84906935174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085722     Document Type: Article

References (46)

1. LeVine A, Whitsett J, Hartshorn K, Crouch E, Korfhagen T (2001) Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 167: 5868-5873. (Pubitemid 33062780)
2. Wright J (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68.
3. Gardai S, Xiao Y, Dickinson M, Nick J, Voelker D, et al. (2003) By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23. (Pubitemid 37255314)
4. Guo C, Atochina-Vasserman E, Abramova E, Foley J, Zaman A, et al. (2008) Snitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 6: e266.
5. Janssen W, McPhillips K, Dickinson M, Linderman D, Morimoto K, et al. (2008) Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med 178: 158-167. (Pubitemid 351957774)
6. Botas C, Poulain F, Akiyama J, Brown C, Allen L, et al. (1998) Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A 95: 11869-11874. (Pubitemid 28460506)
7. Korfhagen T, Sheftelyevich V, Burhans M, Bruno M, Ross G, et al. (1998) Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 273: 28438-28443. (Pubitemid 28496149)
8. Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, et al. (2004) GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. Am J Physiol Lung Cell Mol Physiol 287: L1333-1341. (Pubitemid 39507213)
9. Jung A, Allen L, Nyengaard J, Gundersen H, Richter J, et al. (2005) Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice. Anat Rec A Discov Mol Cell Evol Biol 286: 885-890. (Pubitemid 41434212)
10. Knudsen L, Ochs M, Mackay R, Townsend P, Deb R, et al. (2007) Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SPD deficient mice. Respir Res 8: 70.
11. Atochina E, Beers M, Hawgood S, Poulain F, Davis C, et al. (2004) Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am J Respir Cell Mol Biol 30: 271-279. (Pubitemid 38315379)
12. Atochina-Vasserman E, Beers M, Kadire H, Tomer Y, Inch A, et al. (2007) Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice. J Immunol 179: 8090-8097.
13. Zhang L, Hartshorn K, Crouch E, Ikegami M, Whitsett J (2002) Complementation of pulmonary abnormalities in SP-D(-/-) mice with an SP-D/conglutinin fusion protein. J Biol Chem 277: 22453-22459. (Pubitemid 34967217)
14. Kingma P, Zhang L, Ikegami M, Hartshorn K, McCormack F, et al. (2006) Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem 281: 24496-24505. (Pubitemid 44274224)
15. Wert S, Yoshida M, LeVine A, Ikegami M, Jones T, et al. (2000) Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 97: 5972-5977. (Pubitemid 30367508)
16. Atochina E, Gow A, Beck J, Haczku A, Inch A, et al. (2004) Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis 189: 1528-1539. (Pubitemid 38543603)
17. Atochina-Vasserman E, Abramova E, Tomer Y, Scott P, Nazarov V, et al. (2009) SP-D-dependent regulation of NO metabolism in lipopolysaccharide- stimulated peritoneal macrophages. Bull Exp Biol Med 147: 415-420.
18. Maestrelli P, Páska C, Saetta M, Turato G, Nowicki Y, et al. (2003) Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 21: 971-976. (Pubitemid 36675612)
19. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K (2000) Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162: 701-706. (Pubitemid 30647222)
20. Marshall HE, Stamler JS (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40: 1688-1693.
21. Yoshida M, Korfhagen T, Whitsett J (2001) Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 166: 7514-7519. (Pubitemid 32525630)
22. Mühlfeld C, Knudsen L, Ochs M (2013) Stereology and morphometry of lung tissue. Methods Mol Biol 931: 367-390.
23. Hsia C, Hyde D, Ochs M, Weibel E (2010) An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 181: 394-418.
24. Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M (2010) Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol 108: 412-421.
25. Ochs M, Nyengaard J, Jung A, Knudsen L, Voigt M, et al. (2004) The number of alveoli in the human lung. Am J Respir Crit Care Med 169: 120-124. (Pubitemid 38233898)
26. Fehrenbach A, Ochs M, Wittwer T, Cornelius J, Fehrenbach H, et al. (1999) Stereological estimation of the volume weighted mean volumes of alveoli and acinar pathways in the rat lung to characterise alterations after ischaemia/ reperfusion. J Anat 194 (Pt 1): 127-135. (Pubitemid 29126702)
27. Knudsen L, Waizy H, Fehrenbach H, Richter J, Wahlers T, et al. (2011) Ultrastructural changes of the intracellular surfactant pool in a rat model of lung transplantation-related events. Respir Res 12: 79.
28. Groves AM, Gow AJ, Massa CB, Laskin JD, Laskin DL (2012) Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. Am J Respir Cell Mol Biol 47: 776-783.
29. Gundersen H, Jensen E (1985) Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 138: 127-142. (Pubitemid 15066551)
30. Bates JH, Lutchen KR (2005) The interface between measurement and modeling of peripheral lung mechanics. Respir Physiol Neurobiol 148: 153-164. (Pubitemid 41132756)
31. Ito S, Ingenito EP, Arold SP, Parameswaran H, Tgavalekos NT, et al. (2004) Tissue heterogeneity in the mouse lung: effects of elastase treatment. J Appl Physiol 97: 204-212. (Pubitemid 38802521)
32. Kobayashi A, Hashimoto S, Kooguchi K, Kitamura Y, Onodera H, et al. (1998) Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113: 1632-1639. (Pubitemid 28307170)
33. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. (Pubitemid 41746764)
34. Scotton CJ, Martinez FO, Smelt MJ, Sironi M, Locati M, et al. (2005) Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-13. The Journal of Immunology 174: 834-845. (Pubitemid 40103564)
35. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, et al. (2011) Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 147: 293-305.
36. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S (1996) Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 109: 1006-1009. (Pubitemid 26113645)
37. Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M (2004) Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24: 964-970. (Pubitemid 39642287)
38. Atochina-Vasserman EN, Beers MF, Kadire H, Tomer Y, Inch A, et al. (2007) Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice. J Immunol 179: 8090-8097.
39. Collins RA, Ikegami M, Korfhagen TR, Whitsett JA, Sly PD (2003) In vivo measurements of changes in respiratory mechanics with age in mice deficient in surfactant protein D. Pediatr Res 53: 463-467. (Pubitemid 36237402)
40. Kingma PS, Zhang L, Ikegami M, Hartshorn K, McCormack FX, et al. (2006) Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem 281: 24496-24505. (Pubitemid 44274224)
41. Zhang L, Ikegami M, Crouch EC, Korfhagen TR, Whitsett JA (2001) Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J Biol Chem 276: 19214-19219.
42. Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, et al. (1998) Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. Journal of Biological Chemistry 273: 28438-28443. (Pubitemid 28496149)
43. Wright JR, Dobbs LG (1991) Regulation of pulmonary surfactant secretion and clearance. AnnuRevPhysiol 53: 395-414.
44. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ (1992) Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168-178.
45. Hyde D, Tyler N, Putney L, Singh P, Gundersen H (2004) Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat Rec A Discov Mol Cell Evol Biol 277: 216-226. (Pubitemid 38282841)
46. Weibel E (2009) What makes a good lung? Swiss Med Wkly 139: 375-386.